Neuroendocrine Tumors - Pipeline Review, H1 2017

Market: Pharmaceuticals and Healthcare

Global, 422 pages report, published by Global Markets Direct

Report ThumbnailJune-2017
Neuroendocrine Tumors - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors - Pipeline Review, H1 2017, provides an overview of the Neuroendocrine Tumors (Oncology) pipeline landscape.

Neuroendocrine tumor begins in the hormone-producing cells of the body’s neuroendocrine system, which is made up of cells that are a cross between traditional endocrine cells (or hormone-producing cells) and nerve cells. Symp

Read More
  • List of Figures
  • Number of Products under Development for Neuroendocrine Tumors, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products by Top 10 Targets, H1 2017
  • Number of Products by Stage and Top 10 Targets, H1 2017
  • Number of Products by Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
  • Number of Products by Routes of Administration, H1 2017
  • Number of Products by Stage and Routes of Administration, H1 2017
  • N
Read More
  • List of Tables
  • Number of Products under Development for Neuroendocrine Tumors, H1 2017
  • Number of Products under Development by Companies, H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
  • Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017
  • Number of Products under Development by Universities/Institutes, H1 2017
  • Products under Development by Companies, H1 2017
  • Products under Development by Companies, H1 2017 (Contd..1), H1 2017
  • Produ
Read More
  • Table of Contents
  • Table of Contents 2
  • Introduction 4
  • Neuroendocrine Tumors - Overview 5
  • Neuroendocrine Tumors - Therapeutics Development 6
  • Neuroendocrine Tumors - Therapeutics Assessment 17
  • Neuroendocrine Tumors - Companies Involved in Therapeutics Development 29
  • Neuroendocrine Tumors - Drug Profiles 52
  • Neuroendocrine Tumors - Dormant Projects 398
  • Neuroendocrine Tumors - Discontinued Products 400
  • Neuroendocrine Tumors - Product Development Milestones 401
  • Appendix 413
Read More

Please select a license type

Share

Related Products

Global Markets DirectNeuroendocrine Tumors - Pipeline Review, H1 2017Product ThumbnailNeuroendocrine Tumors - Pipeline Review, H1 2017, Industry ReportProduct #: 828988
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2018 Global Market Analyst. All Rights Reserved